Radiology Podcast | RSNA

Dr. Linda Chu speaks with Dr. Suhny Abbara, the new Editor-in-Chief of Radiology, about his global journey in academic radiology and medical publishing. Dr. Abbara shares his vision for advancing imaging science, embracing innovation such as AI, and shaping the future of the journal to improve patient care.

Dr. Refky Nicola speaks with Dr. Sven Haller about the current clinical use of AI-accelerated MRI, exploring how these techniques improve scan speed, patient comfort, workflow efficiency, and image quality. They also examine key challenges including hallucinations, validation gaps, economic considerations, and the need for clear standards to guide safe and effective adoption.
The Current Status of AI-accelerated MRI Techniques in Clinical Use. Haller et al. Radiology 2025; 317(2):e24381

This episode reviews recent evidence on microwave and radiofrequency ablation as minimally invasive treatments for primary and secondary hyperparathyroidism, highlighting efficacy, safety, and complication profiles compared with surgery. Focusing on a multicenter prospective Radiology study in older patients, the discussion shows that both ablation techniques achieve meaningful biochemical improvement with acceptable risk, particularly as alternatives for patients who may not be ideal surgical candidates.
Efficacy and Safety of Microwave and Radiofrequency Ablationin the Treatment of Hyperparathyroidism in Older Individuals:A Multicenter Prospective Study. Zhang and Liu et al. Radiology 2025; 317(1):e243359.

Dr. Lauren Kim speaks with Dr. Ritu Gill, Professor of Radiology at Columbia University, about the updated ninth edition TNM staging system for pleural mesothelioma, including the new metrics used to quantify pleural tumor in CT imaging.
ARTICLE LINKS:
Editorial: https://pubs.rsna.org/doi/10.1148/radiol.252343
Review: https://pubs.rsna.org/doi/10.1148/radiol.250531

*]:pointer-events-auto [content-visibility:auto] supports-[content-visibility:auto]:[contain-intrinsic-size:auto_100lvh] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" tabindex="-1" data-turn-id= "request-WEB:cee59b98-0957-4b41-b5d5-47fb322bf09a-2" data-testid= "conversation-turn-6" data-scroll-anchor="true" data-turn= "assistant"> Host Dr. Linda Chu speaks with Dr. Jana Ivanidze and Dr. Rajiv Magge about how molecular imaging is transforming the diagnosis and management of breast cancer brain metastases, with an emphasis on precision and personalized care. Their discussion highlights emerging tools such as advanced PET techniques and liquid biopsy that support earlier detection, guide treatment planning, and shape the future of neuro-oncology. Sponsored by GE HealthCare.